JP Jenkins Ltd · ISIN: GB00B2823H99 · EQS - Company News

e-therapeutics plc, Results of Annual General Meeting and Appointment of Jeremy Punnett to the Board of Directors

    16th July 2024 ISIN: GB00B2823H99 JPJ:ETX     e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")    Results of Annual General Meeting and Appointment of Jeremy Punnett to the Board of Directors   London, UK, 16 July 2024 – e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, announces that at its Annual General Meeting held earlier today, all resolutions, as set out in the Notice of Meeting,...

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News JP Jenkins Ltd

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
16 July 2024 05:14PM
e-therapeutics plc, Results of Annual General Meeting and Appointment of Jeremy Punnett to the Board of Directors
    16th July 2024 ISIN: GB00B2823H99 JPJ:ETX     e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")    Results of Annual General Meeting and Appointment of Jeremy Punnett to the Board of Directors   London, UK, 16 July 2024 – e-therapeutics plc, a company integrating computational power and biological data to discover li...
JP Jenkins Ltd
03 July 2024 12:49PM
e-therapeutics announces completion of £28.90 million fundraise
  3rd July 2024 ISIN: GB00B2823H99 JPJ:ETX   e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")    e-therapeutics announces completion of £28.90 million fundraise     London, UK, 3 July 2024 - e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, is p...
JP Jenkins Ltd
23 May 2024 09:32AM
Lord David Prior Appointed as Chair of e-therapeutics’ Board of Directors
    23rd May 2024 JPJ:ETX ISIN: GB00B2823H99     e-therapeutics plc   ("e-therapeutics" or “ETX” or the "Company")    Lord David Prior Appointed as Chair of e-therapeutics’ Board of Directors     London, UK, 23 May 2024 – e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNA...
JP Jenkins Ltd
09 May 2024 08:30AM
e-therapeutics plc shares now trading on JP Jenkins
9th May 2024 JPJ: ETX ISIN: GB00B2823H99   e-therapeutics plc   ("e-therapeutics" or "ETX" or the "Company")   Shares now trading on JP Jenkins   London, UK, 9th May 2024 – e-therapeutics plc (AIM: ETX), a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announces its shares (...
JP Jenkins Ltd
13 November 2023 10:05AM
More to come in RNAi therapy discovery
  London, UK, 13 November 2023   Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery e-therapeutics reported H1 FY24 results (to end-July 2023), reaffirming its commitment to integrating its computational and hepatocyte biology expertise to develop short interfering RNA (siRNA) therapies. The key half-year devel...
Edison Investment Research Limited
More JP Jenkins Ltd related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN